G-CSF Blocking Peptide

Catalog number
5094RBP-50
Name
G-CSF Blocking Peptide
Size
50 μg
Price
245.00 EUR
Supplier

Details

Antibody Target
G-CSF
Accession
NP_757373
Gene ID
1440
Appearance
Colorless liquid
Concentration
0.2 mg/ml
Formulation
50 µg (0.2 mg/ml) in phosphate buffered saline (PBS), pH 7.2, containing 50% glycerol, 1% BSA and 0.02% thimerosal.
Packaging
EA
Storage Temp.
-20 °C
Shipping
gel pack
Shelf Life
1 year
Category
G-CSF
Research Use
For Rersearch Use Only! Not to be used in humans.
Handling
The peptide solution should be gently mixed before use.
Test
You can block the antibody by the specific target amino acid sequence of peptide.
Properties
blocking peptide
Gene
Granulocyte-colony stimulating factor (G-CSF or GCSF), also known as colony-stimulating factor 3 (CSF 3), is a glycoprotein that stimulates the bone marrow to produce granulocytes and stem cells and release them into the bloodstream. Functionally, it is a cytokine and hormone, a type of colony-stimulating factor, and is produced by a number of different tissues. The pharmaceutical analogs of naturally occurring G-CSF are called filgrastim and lenograstim.
Description
Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.